期刊文献+

Progressive multifocal exophytic pontine glioblastoma: a case report with literature review

Progressive multifocal exophytic pontine glioblastoma:a case report with literature review
下载PDF
导出
摘要 Multifocal pontine glioblastoma exhibiting an exophytic growth pattern in the cerebello-pontine angle(CPA) is rare.We present a case of a 5-year-old girl with consecutive neurological imaging and other clinical findings indicating progressive multifocal exophytic pontine glioblastoma.Three lesions were reported,of which two were initially presented,and one was developed 2 months later.One lesion demonstrated a progressing exophytic extension in the cistern of the left side of the CPA.The other two lesions were located and confined within the pons.Initial magnetic resonance imaging and positron emission tomography-computed tomography indicated low-grade glioma or inflammatory disease.However,2 and 3 months later,subsequent magnetic resonance spectroscopy(MRS) displayed elevated choline and depressed N-acetyl aspartate peaks compared with the peaks on the initial MRS,indicating a high-grade glioma.Subtotal resection was performed for the CPA lesion.Histopathologic examination showed discrepant features of different parts of the CPA lesion.The patient received no further chemotherapy or radiotherapy and died 2 months after surgery.The multifocal and exophytic features of this case and the heterogeneous manifestations on neurological images were rare and confusing for both diagnosis and surgical decision-making.Our case report may contribute knowledge and helpful guidance for other medical doctors. Multifocal pontine glioblastoma exhibiting an exophytic growth pattern in the cerebello- pontine angle (CPA) is rare. We present a case of a 5-year-old girl with consecutive neurological imaging and other clinical findings indicating progressive multifocal exophytic pontine glioblastoma. Three lesions were reported, of which two were initially presented, and one was developed 2 months later. One lesion demonstrated a progressing exophytic extension in the cistern of the left side of the CPA. The other two lesions were located and confined within the pons. Initial magnetic resonance imaging and positron emission tomography-computed tomography indicated low-grade glioma or inflammatory disease. However, 2 and 3 months later, subsequent magnetic resonance spectroscopy (MRS) displayed elevated choline and depressed N-acetyl aspartate peaks compared with the peaks on the initial MRS, indicating a high-grade glioma. Subtotal resection was performed for the CPA lesion. Histopathologic examination showed discrepant features of different parts of the CPA lesion. The patient received no further chemotherapy or radiotherapy and died 2 months after surgery. The multifocal and exophytic features of this case and the heterogeneous manifestations on neurological images were rare and confusing for both diagnosis and surgical decision-making. Our case report may contribute knowledge and helpful guidance for other medical doctors.
出处 《Chinese Journal of Cancer》 SCIE CAS CSCD 2017年第7期326-334,共9页
关键词 BRAINSTEM Cerebello-pontine angle GLIOMA Multiple LESION PONTINE Brainstem Cerebello-pontine angle Glioma Multiple lesion Pontine
  • 相关文献

参考文献2

二级参考文献61

  • 1Paravati A J, Heron DE, Landsittel D, et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group- Recursive Partitioning Analysis in the IMRT and temozolomide era. J Neurooncol, 2011,104:339-349.
  • 2Mirimanoff RO, Gorlia T, Mason W, et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol, 2006,24:2563-2569.
  • 3Yang P, Wang Y, Peng X, et al. Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution. J Neurooncol, 2013,113:259-266.
  • 4Louis D, Ohgaki H, Wiestler O, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol, 2007.114:97-109.
  • 5Cairncross G, Wang M, Shaw E, et al. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol, 2013,31:337-343.
  • 6van den Bent M J, Brandes AA, Taphoorn M J, et al. Adjuvant procarbazine, Iomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendrogtioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol, 2013,31:344- 350.
  • 7Weller M, Stupp R, Hegi M, et al. Personalized care in neuro- oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice. Neuro Qncol, 2012,14 Suppl 4:iv100-108.
  • 8Radiation therapy with or without temozolomide in treating patients with anaplastic glioma. ClinicalTrials.gov Identifier:NCT00626990. Verified May 2011 by National Cancer Institute (NCl). ClinicalTrials. gov processed this record on December 01, 2013. http:// clinicaltrials.gov/ct2/show/NCT00626990?term= NCT00626990&ra nk=l.
  • 9Radiation therapy with concomitant and adjuvant temozolomide or radiation therapy with adjuvant PCV or temozolomide alone in treating patients with anaplastic glioma. ClinicalTrials.gov identifier: NCT00887146, Verified November 2013 by Alliance for Clinical Trials in Oncology. ClinicalTrials.gov processed this record on December 01, 2013. http://clinicaltrials.gov/ct2/show/NCTO0887146 ?term=NCTOO887146.&rank= 1.
  • 10Hofer S, Lassman AB. Molecular markers in gliomas: impact for the clinician. Targ Oncol, 2010,5:201-210.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部